The Canine and Feline Parasitology Market1 is forecast to grow at a CAGR of +X% from 2020 to 2035

Key Market Drivers

• Parasitology remains the largest product segment in animal health
• It is a burgeoning sector with numerous growth opportunities in both developed and developing markets
• Established sector with changes in epidemiology and pet owner compliance driving growth
• Flea and tick control to continue being the largest segment
• The market will continue to be dominated by dogs
• The US is largest market in companion animal parasitology, with the highest growth rate expected in APAC-3
• Upcoming genericization of isoxazolines evokes protective lifecycle management
• Improving compliance rates for treating parasites is main unmet need in pet parasitology market

Overall

Parasitology remains the largest segment in animal health, growing at aX% CAGR. Our analysis shows the global market for canine and feline parasitology is projected to reach $X billion, growing by X% between 2020 and 2035. Factors such as growth in companion animal ownership, an increased number of animals at risk due to climate changeinduced influences on epidemiology, and increased awareness and compliance from pet owners are expected to drive growth in the market. Additionally, increasing price levels will drive growth of the companion animal parasitology market value. Price level increases will be driven by innovation in formulation development, such as the introduction of higher priced combination endectocides and innovation regarding new active pharmaceutical ingredient classes, as well as new technologies. At the same time, the increase in price levels will be slowed by higher genericization and intra-innovation competition.

Market by Application

Flea and tick control to remain largest segment, worm control with heartwormclaim growing fastest By application, the flea and tick control segment accounted for X% of the overall canine and feline parasitology market in 2020 and is expected to reach $X billion by 2035, at a CAGR of X%. Key factors driving growth are increased geographic spread and abundance of ticks, and rising awareness regarding risks of tick-borne disease. The worm control with heartworm claim segment accounted for a smaller part of the companion animal parasitology market with X% share in 2020. This segment is expected to grow fastest and to reach $X billion by 2035 at a CAGR of X%. Growth is driven by heartworm becoming a risk in more geographies and during longer periods of the year, among other factors. The worm control without heartworm claim segment is the smallest part of the pet parasitology market with X% share in 2020. This segment is expected to grow to $X billion by 2035 at a CAGR of X%. This comparatively low growth rate is related to the trend towards endectocides, which in most cases include a heartworm claim.

Market by Treatment

Endectocides are forecast to grow fastest at a CAGR X% In relation to type of treatment, ectoparasiticides accounted for the largest share of the companion animal parasitology market in 2020 with a X% share, but this is expected to drop to X% by 2035. The decrease in market share can be attributed to the past and future launch of endectocides that offer more convenience to the pet owner thanks to their 'one-product-fits-all' characteristic. Endoparasiticides accounted for the smallest share of the canine and feline parasitology market in 2020 with X% share. This is expected to drop even more and is again related to the aforementioned trend regarding endectocides. With a CAGR of X%, endectocides are expected to drive growth in the companion animal market substantially. We project this segment to grow from $X billion in 2020 to $X billion in 2035. Download the Sample Report: Canine and Feline Parasitology Market 2020-2035

This article was published by S&P Global Commodity Insights and not by S&P Global Ratings, which is a separately managed division of S&P Global.